查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球皮膚科準分子雷射市場 - 2023-2030
市場調查報告書
商品編碼
1374851

全球皮膚科準分子雷射市場 - 2023-2030

Global Dermatology Excimer Laser Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 187 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

皮膚科準分子雷射是一種利用雷射光束和紫外線B（UVB）光來治療皮膚受影響區域的雷射治療設備。身體的任何部位都可以使用這種雷射療法進行治療，包括頭皮。使用這些雷射治療各種皮膚病被認為非常有效、安全且無痛。準分子雷射僅治療受影響的皮膚區域，而光療裝置則治療所有暴露的皮膚。治療時間通常少於 10-15 分鐘。

此外，在皮膚科準分子雷射中，光以波的形式傳播，某些類型的光波非常長，而另一些類型的波長則相當短。不同波長的光對身體有不同的影響。這種波長的光可以消除導致濕疹症狀的過度活躍的免疫細胞，並可以幫助受白斑影響的皮膚重新著色。當乾癬僅限於較小的皮膚區域（例如手肘、手部、腳部或頭皮）時，準分子雷射治療也可以治療乾癬。這些雷射最常用於治療此類皮膚狀況。

市場動態：促進因素

準分子雷射的採用率不斷提高並不斷進步

皮膚科準分子雷射在各種皮膚疾病中的日益採用以及準分子雷射的不斷進步預計將在預測期內推動市場發展。皮膚科準分子雷射技術的不斷進步帶來了更精確和可客製化的治療方案，特別是對於白斑和牛皮癬。這可以減少對健康組織的損害，並實現更快、更有效的治療。

例如，2022 年 2 月 9 日，STRATA Skin Sciences, Inc. 在美國市場首次安裝了其下一代準分子雷射系統 XTRAC Momentum 1.0。 XTRAC 準分子雷射技術可為患有牛皮癬、異位性皮膚炎和白斑等發炎性皮膚病的成人和兒童患者的特定皮膚治療區域提供精確的靶向 UVB 光療。

此外，STRATA 的新型 XTRAC Momentum 1.0 代表了最新的準分子雷射技術，與目前型號相比，可提供更高的功率和更快的重複率。 Momentum 還提供了新的使用者介面和纖薄的設計，兩者都旨在改善治療體驗。

此外，準分子雷射對於治療牛皮癬特別有效。它們可以精確定位受影響區域，減少健康皮膚的暴露。這導致擴大採用準分子雷射作為牛皮癬患者的主要治療選擇。準分子雷射治療的針對性也對白斑症患者有益，它可以幫助受影響區域重新著色。患者擴大尋求非侵入性和高度針對性的治療，這有助於皮膚科準分子雷射的採用。

例如，2020年8月12日，世界一流的美容和醫學皮膚科雷射設備開發商和製造商LASEROPTEK Co., Ltd.在美國推出了PALLAS固態311nm UVB雷射。有效且安全的 PALLAS 雷射已獲得 FDA 批准，可用於治療白斑症、牛皮癬、異位性皮膚炎和白皮病。 PALLAS 對 308 奈米準分子雷射進行了獨特的技術改進。

此外，牛皮癬、白斑、濕疹等慢性皮膚病的盛行率不斷增加，FDA對更先進雷射的批准不斷增加，意識的提高以及更精確的準分子雷射器開發的進步，預計將在預測期內推動市場發展。

限制

與皮膚科準分子雷射相關的併發症、準分子雷射治療的高成本、與這些雷射技術相關的副作用以及對準分子雷射器缺乏認知等因素預計將阻礙市場。

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 按產品類型分類
  • 按應用程式片段
  • 最終使用者的片段
  • 按地區分類

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 準分子雷射的採用率不斷提高並取得進步
    • 限制
      • 雷射治療的高成本
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 管道分析
  • 未滿足的需求
  • DMI 意見

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：按產品類型

  • 桌上型準分子雷射器
  • 手持式準分子雷射器
  • 推車式準分子雷射器

第 8 章：按應用

  • 白斑
  • 牛皮癬
  • 濕疹
  • 白色疤痕
  • 其他

第 9 章：最終用戶

  • 醫院
  • 皮膚科診所
  • 專科診所
  • 雷射中心
  • 其他

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • STRATA Skin Sciences, Inc.
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Shenzhen GSD Tech Co., Ltd.
  • Alma Lasers
  • Kernel Medical Equipment Co.,LTD.
  • Timpac Healthcare Pvt. Ltd.
  • KRUPA MEDI SCAN
  • Komachine Inc.
  • Optosystems Ltd.
  • DermSA
  • PhotoMedex, Inc.

第 13 章：附錄

簡介目錄
Product Code: MD7384

Overview

Dermatology excimer laser is a device used for laser therapy by using the laser beam with ultraviolet B (UVB) light to treat the affected areas of skin. Any area of the body can be treated with this laser therapy, including the scalp. The treatment of various skin conditions with these lasers is considered highly effective, safe and painless. The excimer laser treats only the affected areas of skin as opposed to a phototherapy unit which treats all exposed skin. Treatment time is typically less than 10-15 minutes.

Moreover, in dermatology excimer lasers, light travels in waves, some types of light waves are very long and other wavelengths are quite short. Light of different wavelengths can have different effects on the body. This wavelength of light can eliminate the overactive immune cells that cause symptoms of eczema and can help re-pigment skin affected by vitiligo. Excimer laser treatments can also treat psoriasis when the condition is confined to smaller patches of skin, such as the elbows, hands, feet, or scalp. These lasers are most commonly used for such skin conditions.

Market Dynamics: Drivers

Increasing adoption and increasing advancements in excimer lasers

The increasing adoption of dermatology excimer lasers in various skin disorders and increasing advancements in excimer lasers are expected to drive the market over the forecast period. Ongoing advancements in dermatology excimer laser technology led to even more precise and customizable treatment options, especially for vitiligo and psoriasis. This results in reduced damage to healthy tissue and quicker, more effective treatments.

For instance, on February 09, 2022, STRATA Skin Sciences, Inc. launched the first installation in the U.S. market, of its next-generation excimer laser system, XTRAC Momentum 1.0. The XTRAC excimer laser technology allows for the precise delivery of targeted UVB light therapy to specific skin treatment areas, for both adult and pediatric patients suffering from inflammatory skin conditions such as psoriasis, atopic dermatitis and vitiligo.

Moreover, STRATA's new XTRAC Momentum 1.0 represents the latest in excimer laser technology, delivering higher power and a faster repetition rate than the current models. The Momentum also offers a new user interface and slim design, both intended to improve the treatment experience.

In addition, excimer lasers are particularly effective in treating psoriasis. They offer precise targeting of affected areas, reducing exposure to healthy skin. This has led to increased adoption of excimer lasers as a primary treatment option for psoriasis patients. The targeted nature of excimer laser therapy is also beneficial for vitiligo patients, where it can help repigment the affected areas. Patients are increasingly seeking non-invasive and highly targeted treatments, contributing to the adoption of the dermatology excimer lasers.

For instance, on August 12, 2020, LASEROPTEK Co., Ltd., a developer and manufacturer of world-class laser devices for aesthetic and medical dermatology, launched its PALLAS Solid-State 311nm UVB laser in the United States. The efficacious and safe PALLAS laser is FDA-cleared for the treatment of vitiligo, psoriasis, atopic dermatitis and leukoderma. PALLAS features unique technology improvements over 308-nanometer excimer lasers.

Further, the increasing prevalence of chronic skin conditions like psoriasis, vitiligo, eczema and others, rising FDA approvals for more advanced lasers, increasing awareness and advancements in the development of more precise excimer lasers are the factors expected to drive the market over the forecast period.

Restraints

Factors such as complications associated with dermatology excimer lasers, high cost of the excimer laser therapy, side effects associated with these laser techniques and lack of awareness about the excimer lasers are expected to hamper the market.

Segment Analysis

The global dermatology excimer laser market is segmented based on product type, application, end-user and region.

The psoriasis segment accounted for approximately 49.8% of the dermatology excimer laser market share

The psoriasis segment is expected to hold the largest market share over the forecast period. The dermatology excimer lasers emit a specific wavelength of ultraviolet B light, which can be precisely targeted to affected areas of the skin. This focused treatment minimizes exposure to healthy skin, reducing the risk of side effects commonly associated with broader UVB exposure. In case of psoriasis, excimer lasers are used to slow down the growth of skin cells in affected areas and reduce inflammation, helping to manage and alleviate the symptoms of psoriasis.

Additionally, using excimer lasers for psoriasis patients results in faster clearing of psoriatic lesions compared to other treatment methods and the therapy is generally well-tolerated so this therapy is most commonly used. Patients are mostly preferring this therapy due to its non-invasive nature.

Moreover, the increasing prevalence of psoriasis is expected to the increasing adoption of dermatology excimer lasers. For psoriasis patients, excimer laser therapy provides relief that lasts several months, improves symptoms in just 6-12 sessions, is known for a quick, easy treatment that doesn't require to application of creams or products every day, provides long-term symptom remission and it also provides pain-free and non-invasive treatment.

For instance, according to the National Psoriasis Foundation, 2022, more than 8 million Americans have psoriasis. 125 million people worldwide, 2 to 3 percent of the total population have psoriasis, according to the World Psoriasis Day consortium. Psoriasis prevalence in African Americans is 1.5 percent compared to 3.6 percent of Caucasians.

Geographical Analysis

North America accounted for approximately 40.4% of the market share

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing adoption of dermatology excimer lasers to treat various types of skin conditions. North America especially the United States is known for its strong presence of major players such as medical device companies and biotechnology companies which are actively focussing on the development of more advanced and precise dermatology excimer lasers for better patient outcomes. This presence of major players performs research activities for the advancements in the excimer lasers.

Furthermore, increasing adoption of dermatology excimer lasers is also expected to drive the market in the region. The region is also known for the increasing prevalence of various skin conditions, this increasing prevalence is expected to increase the demand and adoption of dermatology excimer lasers.

For instance, according to the National Eczema Association, 31.6 million people in the U.S. have some form of eczema, and prevalence peaks during early childhood and according to the National Psoriasis Foundation, more than 8 million Americans have psoriasis. This increasing prevalence of skin conditions in the region is expected to increase the adoption of dermatology excimer lasers for better treatment of skin disorders.

Competitive Landscape

The major global players in the dermatology excimer laser market include: STRATA Skin Sciences, Inc., Shenzhen GSD Tech Co., Ltd., Alma Lasers, Kernel Medical Equipment Co., LTD., Timpac Healthcare Pvt. Ltd., KRUPA MEDI SCAN, Komachine Inc., Optosystems Ltd., DermSA and PhotoMedex, Inc. among others.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global dermatology excimer laser market. During the pandemic, patients with dermatological conditions like psoriasis, who would have otherwise sought treatment with excimer lasers are delayed or avoided in-person visits to healthcare facilities. This was due to concerns and redirected focus towards virus exposure, restrictions on non-essential healthcare services and the reprioritization of healthcare resources. The pandemic also disrupted the supply chain of these medical devices globally due to border closures.

Market Segmentation

By Product Type

  • Table Top Excimer Lasers
  • Hand-Held Excimer Lasers
  • Trolley Mounted Excimer Lasers

By Application

  • Vitiligo
  • Psoriasis
  • Eczema
  • White Scars
  • Others

By End-User

  • Hospitals
  • Dermatology Clinics
  • Specialty Clinics
  • Laser Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Why Purchase the Report?

  • To visualize the global dermatology excimer laser market segmentation based on product type, application, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development
  • Excel data sheet with numerous data points of dermatology excimer laser market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global dermatology excimer laser market report would provide approximately 61 tables, 61 figures, and 187 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Adoption and Advancements in Excimer Lasers
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of the Laser Therapy
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Pipeline Analysis
  • 5.6. Unmet Needs
  • 5.7. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Table Top Excimer Lasers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Hand-Held Excimer Lasers
  • 7.4. Trolley Mounted Excimer Lasers

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Vitiligo*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Psoriasis
  • 8.4. Eczema
  • 8.5. White Scars
  • 8.6. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Dermatology Clinics
  • 9.4. Specialty Clinics
  • 9.5. Laser Centers
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. STRATA Skin Sciences, Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Shenzhen GSD Tech Co., Ltd.
  • 12.3. Alma Lasers
  • 12.4. Kernel Medical Equipment Co.,LTD.
  • 12.5. Timpac Healthcare Pvt. Ltd.
  • 12.6. KRUPA MEDI SCAN
  • 12.7. Komachine Inc.
  • 12.8. Optosystems Ltd.
  • 12.9. DermSA
  • 12.10. PhotoMedex, Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us